Oral drug shows promise in di­a­bet­ic mac­u­lar ede­ma as biotech touts an­ti-VEGF in­jec­tion al­ter­na­tive

An ex­per­i­men­tal pill for di­a­bet­ic mac­u­lar ede­ma has shown promis­ing ef­fects on a key bio­mark­er in a proof-of-con­cept study, fu­el­ing hope that it can be­come …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER